Zymergen: Zymergen Investors Can't Beat Suit Over Pre-IPO Statements
Three of the largest investors of biotechnology company Zymergen cannot escape a suit accusing them of misleading shareholders ahead of the company's initial public offering by approving misstatements about the company's commercial product pipeline.
Read full article »
Zymergen is a California-based biotechnology company that designs and produces molecules, microbes and materials for agriculture, packaging and manufacturing industries.
Read more